文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

危重症休克患者延迟动脉置管

Deferring Arterial Catheterization in Critically Ill Patients with Shock.
PubMed 文献 · N Engl J Med · 2025-10-29
一句话结论休克患者不早期置入动脉导管、改用自动袖带监测血压,28天全因死亡不劣于早期置管(34.3% vs 36.9%,校正风险差-3.2个百分点,95%CI -8.9至2.5)。

该多中心、开放标签、非劣效性试验纳入ICU入院24小时内的休克患者1010例,随机分为早期(随机后<4小时)置入动脉导管组(有创策略)与自动肱动脉袖带监测组(无创策略);无创组若符合预设安全标准可后期置管。主要终点为28天全因死亡,非劣效界值5个百分点。无创策略组28天死亡34.3%(173例),有创策略组36.9%(185例),校正风险差-3.2个百分点(95%CI -8.9至2.5),非劣效P=0.006。无创组血肿或出血5例(1.0%),有创组41例(8.2%)。

要点

  • 休克患者不早期置入动脉导管、以自动肱动脉袖带监测血压,28天全因死亡34.3% vs 早期置管36.9%,校正风险差-3.2个百分点(95%CI -8.9至2.5),达到非劣效(界值5个百分点,P=0.006)。
  • 无创策略组仅14.7%(74例)最终置入动脉导管,有创策略组98.2%(493例)置入,提示多数休克患者可先不置管。
  • 无创策略组因血压监测装置持续存在而出现至少1天疼痛或不适者13.1%(66例),有创策略组9.0%(45例)。
  • 动脉导管相关血肿或出血无创策略组1.0%(5例),有创策略组8.2%(41例)。
  • 无创策略组患者若符合预设安全标准,允许后期置入动脉导管。

适用人群与场景

  • 休克患者,且在过去24小时内入住重症监护室。

诊断标准与关键阈值

  • 非劣效界值为5个百分点(主要终点28天全因死亡)。
  • 无创策略组患者符合预设安全标准时允许后期置入动脉导管。

处置流程与药物剂量

  • 有创策略:随机后<4小时内置入动脉导管。
  • 无创策略:使用自动肱动脉袖带监测血压,符合预设安全标准时可后期置入动脉导管。

研究设计与关键结果

  • 多中心、开放标签、非劣效性试验,1010例患者随机,无创策略组504例、有创策略组502例纳入分析。
  • 28天全因死亡:无创策略组34.3%(173例) vs 有创策略组36.9%(185例),校正风险差-3.2个百分点(95%CI -8.9至2.5),非劣效P=0.006。
  • 动脉导管置入率:无创策略组14.7%(74例) vs 有创策略组98.2%(493例)。
  • 血压监测装置相关至少1天疼痛或不适:无创策略组13.1%(66例) vs 有创策略组9.0%(45例)。
  • 动脉导管相关血肿或出血:无创策略组1.0%(5例) vs 有创策略组8.2%(41例)。
  • 符合方案分析两组结果相似。

证据类型、等级与局限

  • 证据类型:多中心、开放标签、非劣效性随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对ICU内休克患者,可先采用自动肱动脉袖带监测血压而不早期置入动脉导管,28天死亡不劣于早期置管。
  • 无创策略组患者符合预设安全标准时可后期置入动脉导管。
  • 无创策略组动脉导管相关血肿或出血少于有创策略组(1.0% vs 8.2%),但血压监测装置相关疼痛或不适多于有创策略组(13.1% vs 9.0%)。

指南或共识出处

  • ClinicalTrials.gov注册号NCT03680963;法国卫生部资助。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: In patients with shock, whether noninvasive blood-pressure monitoring is an effective alternative to the recommended use of an arterial catheter is uncertain.

METHODS: In this multicenter, open-label, noninferiority trial, we randomly assigned patients who had shock and had been admitted to an intensive care unit within the past 24 hours to receive early insertion (<4 hours after randomization) of an arterial catheter (invasive strategy) or to be monitored with an automated brachial cuff (noninvasive strategy). Insertion of an arterial catheter was allowed later in patients assigned to the noninvasive-strategy group who met prespecified safety criteria. The primary outcome was death from any cause at day 28 (noninferiority margin, 5 percentage points). Adverse events of special interest related to the blood-pressure-monitoring device that was used were recorded, as was patient-reported pain or discomfort related to the ongoing presence of the device.

RESULTS: A total of 1010 patients underwent randomization; 504 patients assigned to the noninvasive-strategy group and 502 assigned to the invasive-strategy group were included in the analyses. A total of 74 patients (14.7%) in the noninvasive-strategy group and 493 (98.2%) in the invasive-strategy group underwent insertion of an arterial catheter. Death within 28 days occurred in 173 patients (34.3%) in the noninvasive-strategy group and 185 (36.9%) in the invasive-strategy group (adjusted risk difference, -3.2 percentage points; 95% confidence interval, -8.9 to 2.5; P = 0.006 for noninferiority). Results of per-protocol analyses were similar in the two groups. A total of 66 patients (13.1%) in the noninvasive-strategy group and 45 (9.0%) in the invasive-strategy group had at least 1 day of pain or discomfort related to the ongoing presence of the blood-pressure-monitoring device. Hematoma or hemorrhage related to the arterial catheter occurred in 5 patients (1.0%) in the noninvasive-strategy group and 41 patients (8.2%) in the invasive-strategy group.

CONCLUSIONS: Among patients with shock, results for death from any cause at day 28 indicated that management without early arterial catheter insertion was noninferior to early catheter insertion. (Funded by the French Ministry of Health; ClinicalTrials.gov number, NCT03680963.).

来源:N Engl J Med,查看原文。版权归原作者所有。

参考来源

  1. Muller G, Contou D, Ehrmann S, et al. Deferring Arterial Catheterization in Critically Ill Patients with Shock. N Engl J Med. 2025. PMID: 41159885. doi:10.1056/NEJMoa2502136

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。